ACRS position history
The shares of Aclaris Therapeutics (ACRS) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q1: 569,832 shares, $707K, 0.08% of portfolio, New
- 2024 Q2: 569,832 shares, $627K, 0.07% of portfolio
- 2024 Q3: 569,832 shares, $655K, 0.09% of portfolio
- 2024 Q4: 569,832 shares, $1.4M, 0.22% of portfolio
- 2025 Q1: 776,028 shares, $1.2M, 0.23% of portfolio, Add +36.2%
- 2025 Q2: 1,390,028 shares, $2M, 0.42% of portfolio, Add +79.1%
- 2025 Q3: 1,566,840 shares, $3M, 0.55% of portfolio, Add +12.7%
- 2025 Q4: 1,566,840 shares, $4.7M, 0.66% of portfolio
- 2026 Q1: 1,613,430 shares, $6.1M, 0.93% of portfolio, Add +3.0%
- 2026 Q2: 1,613,430 shares, $8.5M, 1.2% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|